Skip to main content

Research Repository

Advanced Search

Using Artificial Intelligence (AI) to enhance pharmacovigilance and side-effect reporting of new drugs

People Involved

Project Description

The proposed PhD research will be conducted as part of the esteemed UK EPSRC funded COG-MHEAR research program, which aims to revolutionize the field of hearing assistive technology through the development of personalized multimodal solutions. This research project will focus on tackling crucial challenges in pharmacovigilance AI, specifically in evaluating online and social media forums to assess the impact of key drugs, both commonly used and new, on age-related hearing and cognitive impairment, including cognitive loss or listening effort.
The objective is to correlate the findings with existing harmacovigilance studies conducted by drug manufacturers, government organizations, and researchers. The insights gained from this research will significantly contribute to enhancing the context-aware personalized design of multimodal hearing aid prototypes currently under development within the COG-MHEAR program. By enabling the data-driven integration of historical and ongoing drug use, the PhD outcomes aim to empower COG-MHEAR AI prototype models to better predict and address the cognitive load experienced by hearing-aid users

Status Project Live
Funder(s) Bawazeer group
Value £36,653.00
Project Dates Oct 1, 2024 - Sep 30, 2027
Partner Organisations Bawazeer Group



You might also like

Electrolysed Water for Post-Harvest Washing (JadooJal) Mar 1, 2017 - Aug 31, 2019
assist the development of a novel electrolysed water based application to reduce spoilage and microbial contamination of a variety of fresh produce types of importance to Indian commerce.